SMO and meningioma: Recently developed sequencing technologies (“next‐generation sequencing”) have revealed the genomic and epigenetic landscapes of meningiomas.[5] The identification of genetic alterations such as NF2, AKT1, TRAF7, SMO, and PIK3CA offers insight into the molecular mechanisms of tumorigenesis in meningiomas.